Skip to main content Back to Top
Advertisement

1/24/2020

Midazolam Injection

Products Affected - Description

    • Midazolam injection, Athenex, 5 mg/mL, 5 mL vial, 10 count, NDC 70860-0601-05
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0002-10
    • Midazolam injection, Pfizer, 1 mg/mL, 10 mL vial, 10 count, NDC 00409-2587-05
    • Midazolam injection, Pfizer, 1 mg/mL, 2 mL preservative-free Luer Lock syringe, 10 count, NDC 00409-2306-62
    • Midazolam injection, Pfizer, 1 mg/mL, 2 mL preservative-free iSecure syringe, 10 count, NDC 00409-2306-12
    • Midazolam injection, Pfizer, 5 mg/mL, 1 mL preservative-free Luer Lock syringe, 10 count, NDC 00409-2307-60

Reason for the Shortage

    • Athenex did not provide a reason for the shortage.
    • Fresenius Kabi has midazolam injection on back order due to increased demand.
    • Hikma has midazolam injection available.
    • Pfizer has midazolam injection on shortage due to manufacturing delays.

Available Products

    • Midazolam injection, Akorn, 5 mg/mL, 10 mL vial, 10 count, NDC 17478-0524-10
    • Midazolam injection, Athenex, 1 mg/mL, 2 mL vial, 25 count, NDC 70860-0600-02
    • Midazolam injection, Athenex, 5 mg/mL, 10 mL vial, 10 count, NDC 70860-0601-10
    • Midazolam injection, Fresenius Kabi, 1 mg/mL, 10 mL vial, 10 count, NDC 63323-0411-10
    • Midazolam injection, Fresenius Kabi, 1 mg/mL, 2 mL prefilled syringe, 24 count, NDC 76045-0001-20
    • Midazolam injection, Fresenius Kabi, 1 mg/mL, 2 mL vial, 25 count, NDC 63323-0411-12
    • Midazolam injection, Fresenius Kabi, 1 mg/mL, 5 mL vial, 25 count, NDC 63323-0411-25
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 1 mL fill in 2 mL vial, 25 count, NDC 63323-0412-25
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 10 mL vial, 10 count, NDC 63323-0412-10
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 2 mL prefilled syringe, 24 count, NDC 76045-0003-20
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 2 mL vial, 25 count, NDC 63323-0412-02
    • Midazolam injection, Fresenius Kabi, 5 mg/mL, 5 mL vial, 10 count, NDC 63323-0412-05
    • Midazolam injection, Hikma, 1 mg/mL, 10 mL vial, 10 count, NDC 00641-6056-10
    • Midazolam injection, Hikma, 1 mg/mL, 2 mL vial, 25 count, NDC 00641-6057-25
    • Midazolam injection, Hikma, 1 mg/mL, 5 mL vial, 10 count, NDC 00641-6059-10
    • Midazolam injection, Hikma, 5 mg/mL, 1 mL vial, 25 count, NDC 00641-6061-25
    • Midazolam injection, Hikma, 5 mg/mL, 10 mL vial, 10 count, NDC 00641-6060-10
    • Midazolam injection, Hikma, 5 mg/mL, 2 mL vial, 25 count, NDC 00641-6063-25
    • Midazolam injection, Pfizer, 1 mg/mL, 2 mL preservative-free vial, 25 count, NDC 00409-2305-17
    • Midazolam injection, Pfizer, 1 mg/mL, 5 mL preservative-free vial, 10 count, NDC 00409-2305-05
    • Midazolam injection, Pfizer, 5 mg/mL, 1 mL preservative-free vial, 10 count, NDC 00409-2308-01
    • Midazolam injection, Pfizer, 5 mg/mL, 10 mL vial, 10 count, NDC 00409-2596-05
    • Midazolam injection, Pfizer, 5 mg/mL, 2 mL preservative-free vial, 10 count, NDC 00409-2308-02
    • Midazolam injection, Pfizer, 5 mg/mL, 5 mL vial, 10 count, NDC 00409-2596-03

Estimated Resupply Dates

    • Athenex has midazolam 5 mg/mL 5 mL vials on back order and the company estimates a release date of April 2020.
    • Fresenius Kabi has short-dated midazolam 5 mg/mL 1 mL syringes available with expiration dates of <4 months.
    • Pfizer has midazolam 1 mg/mL 2 mL Carpuject syringes and 5 mg/mL 1 mL Carpuject syringes on back order and the company estimates a release date of June 2021. The 1 mg/mL 2 mL iSecure syringes are on back order and the company estimates a release date of December 2021. Midazolam 1 mg/mL 10 mL multi-dose vials are on back order and the company estimates a release date of March 2020.

Updated

Updated January 24, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 25, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.